Teva Pharmaceutical Industries (TEVA) Net Equity Issued and Repurchased (2015 - 2016)
Teva Pharmaceutical Industries' (TEVA) quarterly Net Equity Issued and Repurchased came in at $329.0 million in Q1 2016, down 90.0% quarter-over-quarter from $3.3 billion in Q4 2015.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Net Equity Issued and Repurchased (2015 - 2016) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $329.0 million the latest figure, recorded in Q1 2016.
- For the quarter ending Q1 2016, Net Equity Issued and Repurchased changed N/A year-over-year to $329.0 million; the trailing twelve-month figure through Dec 2016 stood at $329.0 million (down 90.0% YoY), and the FY2016 full-year result was $329.0 million, down 90.0% from the prior year.
- Net Equity Issued and Repurchased retreated to $329.0 million in Q1 2016 per TEVA's latest filing, from $3.3 billion in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.3 billion in Q4 2015 and bottomed at $329.0 million in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | 700,000.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |